FWD launches innovative “One&All Medical Insurance Plan” with coverage options segmented by hospital type to suit different needs

Partners with Hong Kong Pharmaceutical Care Foundation to support the public with professional drug consultation and medication management services

HONG KONG SAR – Media OutReach Newswire – 18 August 2025 – FWD Hong Kong (“FWD”) has announced the launch of “One&All Medical Insurance Plan” (“One&All”). True to its name, One&All integrates Environmental, Social, and Governance (ESG) principles into its design, offering flexible and affordable medical protection for all. According to a recent survey by the Census and Statistics Department¹, over half of Hong Kong’s citizens do not have personal medical insurance, highlighting a significant protection gap in the market. Furthermore, the cost of self-financed treatments and medicines may be underestimated if relying solely on public hospital coverage. FWD introduces “One&All” to address the need by bridging the gap. The plan specifically targets Hong Kong public hospitals’ self-financed items and imaging tests referred to private medical institutions, enabling more people to access the medical support they need.

FWD also announced its partnership with the Hong Kong Pharmaceutical Care Foundation to offer a first-in-the-market² drug consultation and medication management service for customers of “One&All” and other designated medical insurance products, further enhancing their health management experience.

A customer-led solution to address pain points in public healthcare

Kelvin Yu, Chief Product Officer, FWD Hong Kong & Macau, said: “Government statistics³ show that approximately 3% of patients incur over HKD 10,000 in public hospital expenses, while the annual out-of-pocket medication costs for cancer patients can reach up to HKD 400,000. The self-financed costs for drugs and medical items in the public healthcare system create a significant financial burden for many families. FWD has always been committed to a customer-first approach, striving to bridge the public’s health protection gap with innovative products. The newly launched “One&All Medical Insurance Plan” incorporates ESG principles to offer more accessible and affordable protection for our customers and the community. “One&All“ offers coverage segmented by hospital type, addressing the pain points of those who lack adequate medical protection, such as the inability to afford high-cost self-financed items in public hospitals, or the risk of missing the crucial treatment window due to long waiting times for imaging tests in the public system. Optional benefit can also be applied for parents without any health underwriting.”

Kelvin added: “FWD is also actively expanding its medical partnership network. We are delighted to collaborate with the Hong Kong Pharmaceutical Care Foundation to provide customers of One&All and other designated plans with a first-in-the-market², pharmacist-led drug consultation and medication management service. This allows us to offer comprehensive health support that goes beyond the insurance policy itself.”

Flexible protection across three benefit levels to suit different budgets and medical needs

The innovative “One&All Medical Insurance Plan” is flexibly designed with three benefit levels, allowing customers to choose their protection based on geographical region, as well as public and private hospital categories, catering to diverse budgets and cross-border medical needs:

• Level Access: Features simplified underwriting⁴ with only three simple health questions for enrolment, and daily premium being less than HKD3 ⁵. It is designed to provide basic protection for the uninsured, covering self-financed items in Hong Kong public hospitals and referrals to private facilities for imaging tests⁶ to reduce waiting time. It also offers cash benefits for income loss due to hospitalisation worldwide or day surgeries. The aggregate limit is up to HKD 500,000 per disability⁷ per policy year.
• Level Beyond: In addition to the benefits of Level Access, this level extends coverage to treatment expenses in public and private hospitals across Mainland China and Macau. Designed to meet the growing demand for cross-border medical treatment, this plan offers Cross-border Medical Services at the Greater Bay at a more affordable premium. The aggregate limit is up to HKD 850,000 per disability⁷ per policy year.
• Level Connect: Covers all benefits from Level Access and Level Beyond, and extends coverage to all public and private hospitals across Asia⁸, including Hong Kong and Mainland China. The aggregate limit is up to HKD 1,000,000 per disability⁷ per policy year. Uniquely, this plan allows customers to add an optional benefit⁹ for their parents. This feature is targeted at the problem of securing coverage for parents, as they can be added to the plan with no health underwriting or in-person signing required. Coverage similar to Level Access can be enjoyed after the waiting period.

Expanding network of medical partners to help customers address medication concerns

As part of its ongoing network expansion, FWD collaborates with the Hong Kong Pharmaceutical Care Foundation to offer first-in-the-market² drug consultation and management services, providing eligible customers¹⁰ with comprehensive health management that extends beyond medical insurance to address any medication-related concerns.

S C Chiang, Director, Hong Kong Pharmaceutical Care Foundation, said: “With the rapid advancement of medical technology today, the range of available medication is constantly increasing. When faced with complex prescriptions, many people struggle to obtain adequate consultation and guidance, which can lead to uncertainty and may even impact treatment outcomes if medications are not used correctly. As a non-profit charitable organisation dedicated to enhancing public medication safety and promoting the professional services of pharmacists, we deeply understand the importance of safe medication use. Through this collaboration, we will provide FWD customers with professional drug consultation and management services. This will offer them clearer guidance on their medication and ensure they receive more comprehensive and personalised health management support.”

“One&All“ customers will have access to professional drug consultation and management services, including:

• General drug inquiry service: A remote consultation service that allows customers to easily resolve medication-related queries from the comfort of their home
• Professional pharmacist medication management service: One-on-one, personalised medication consultation and management services from a registered pharmacist
• Dispensary discount

The “One&All Medical Insurance Plan” is underwritten by FWD Life Insurance Company (Bermuda) Limited (incorporated in Bermuda with limited liability) (“FWD”). The above content is for reference only and does not constitute the full terms of coverage. Coverage is subject to the terms and conditions of the policy. For complete terms and conditions, benefits, exclusions, key product risks, and/or other details of the plan, please refer to the FWD website and relevant product brochure: https://www.fwd.com.hk/en/medical-cover/one-n-all-medical-insurance-plan/.

1. Thematic Household Survey Report No. 78, Census and Statistics Department (https://www.censtatd.gov.hk/tc/press_release_detail.html?id=5515).
2. Per a comparison made by FWD with major insurance companies in Hong Kong on 28 July 2025, FWD is the first insurer to collaborate with the Hong Kong Pharmaceutical Care Foundation to offer this service.
3. Source: Secretary for Health, Professor Lo Chung-mau, in a media interview (https://news.hket.com/article/3781692).
4. Applicable to individuals with an age next birthday of 1 to 65. For underwriting requirements, terms, and conditions, please refer to the full underwriting questions.
5. According to standard premium (excluding any rider premiums, premium discounts and levies), calculated based on an insured of age 28 (next birthday) and an annual premium payment for One&All Medical Insurance Plan (Level Access). The standard premium is non-guaranteed and will be determined annually based on the insured’s actual age at renewal.
6. Tests covered include computed tomography (“CT” scan), magnetic resonance imaging (“MRI” scan), positron emission tomography (“PET” scan), PET-CT combined, PET-MRI combined, X-ray, mammogram, bone densitometry, and ultrasound. The list of designated diagnostic imaging tests, day surgeries, and healthcare service providers (hereinafter referred to as the “List”) will be published on the FWD website (www.fwd.com.hk/en/support/medical-support/). FWD reserves the right to add, modify, or replace items on the List from time to time without prior notice. Any changes will take effect on the date specified in the updated List. FWD recommends that policyholders and/or insured persons consult the latest List on the FWD website before undergoing any designated diagnostic imaging tests or day surgeries.
7. a. For each hospitalisation or day surgery due to the same illness, the applicable benefit limit and/or per-illness annual policy year limit will reset, provided that the hospitalisation or day surgery does not occur within 90 consecutive days from the last discharge date or day surgery date related to the same illness.
   b. If the insured person is hospitalised or undergoes day surgery for more than one illness during the same confinement or day surgery session, all illnesses involved will be subject to a single applicable benefit limit and/or per-illness annual policy year limit.
8. Asia includes Afghanistan, Australia, Bangladesh, Bhutan, Brunei, Cambodia, Mainland China, Hong Kong, India, Indonesia, Japan, Kazakhstan, Kyrgyzstan, Laos, Macau, Malaysia, Maldives, Mongolia, Myanmar, Nepal, New Zealand, North Korea, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Tajikistan, Thailand, Timor-Leste, Turkmenistan, Uzbekistan, and Vietnam.
9. The “Family Booster for Parent Option” is an optional benefit available when the policyholder selects Level Connect of the plan. Any benefit amount paid under the Family Booster for Parent Option will not count toward any applicable benefit limits under this plan and will not affect the insured person’s eligibility for benefits and/or no-claim premium discounts under this plan.
10. “Eligible customers” refer to insured persons under designated medical insurance plans. “Designated medical insurance plans” refer to the One&All Medical Insurance Plan. Designated insurance products are subject to availability, and FWD reserves the sole and absolute discretion to amend the definition of designated insurance products from time to time without prior notice. For detailed terms and conditions of the product policy, please refer to the product brochure and policy document.

Hashtag: #FWD

The issuer is solely responsible for the content of this announcement.

About FWD Hong Kong

FWD Hong Kong is part of the FWD Group, a pan-Asian life and health insurance business that serves approximately 30 million customers across 10 markets, including BRI Life in Indonesia.

FWD Hong Kong has been assigned strong financial ratings by international agencies. It offers life and medical insurance, employee benefits, and financial planning.

FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 1828.

For more information about FWD Hong Kong, please visit www.fwd.com.hk.

About the Hong Kong Pharmaceutical Care Foundation

Founded in 2007, the Hong Kong Pharmaceutical Care Foundation is a registered non-profit charitable organisation. The foundation was founded by pharmacists who aim to provide pharmaceutical services and improve public medication use by using their expertise and professional knowledge. The foundation offers services such as Visiting pharmacist service, Drug knowledge and drug management training, Community individualised drug reconciliation and packaging service, Telephone drug counselling, Dispensing of self-financed items (SFI) and drug counselling by pharmacists with subsidy schemes.